Can NIB shares reach $9 by Christmas?

It has been a good few weeks for shareholders. Can the stock keep going?

| More on:
ASX share price movement represented by doctor pressing digitised screen with array of icons including one entitled health insurance,

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The NIB Holdings Limited (ASX: NHF) share price has risen 8% since 8 November 2023 to reach $7.70. Is it possible the NIB share price could go up another 17% to $9 by Christmas?

The ASX healthcare share mainly offers exposure to private health insurance for Australian residents, but it also offers things like non-Australian private health insurance, travel insurance and has growing exposure to the NDIS.

Christmas is only 20 days away, which is a very short timeframe in investment terms. I believe investors should focus on long-term investing, but it's good to consider the outlook for NIB shares.

Expert view on the NIB share price

NIB recently released its AGM trading update for the first few months of FY24, which showed "overall volume and topline momentum is generally upbeat" in UBS' words.

Since June 2023, the Australian resident health insurance division has seen policy numbers rise by 1.3%, implying growth is "tracking towards the top end of the FY24 guidance range of 3% to 4%." Premium growth of 10.5% is tracking ahead of UBS' estimate.

In the international health insurance division, policy numbers have "maintained strong momentum", with 5.2% growth since June 2023, ahead of UBS' forecasts. UBS said premium growth ahead of policy growth indicates repricing support – the broker thinks there is further margin expansion ahead.

In New Zealand, growth is tracking at the low end, while travel policy numbers and premiums were both down in the double-digits because of the end of the Qantas Airways Limited (ASX: QAN) distribution arrangement in July. The Woolworths Group Ltd (ASX: WOW) contract will start contributing in the second half of FY24.

UBS also pointed to claims indicators suggesting that "claims inflation remains under control". Though the company did not detail claims costs in the first quarter of FY24, there are "potential efficiency gains". The broker also suggested recent Medicare monthly data has "generally been supportive."

Forecasts for the ASX healthcare share

The broker has forecast that NIB could generate earnings per share (EPS) of 48 cents and pay an annual dividend per share of 34 cents. That would put the current NIB share price at 16 times FY24's estimated earnings with a grossed-up dividend yield of 6.3%.

The broker rating on NIB shares is a buy, with a price target of $9.50. A price target is for 12 months, not for Christmas, but it does suggest that NIB shares could rise 24% over the next year if UBS ends up being correct.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended NIB Holdings. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

ResMed share price healthcare asx share price flat represented by doctor shrugging
Healthcare Shares

Will the CSL share price beat the market in 2025?

Let's see what analysts are predicting for this biotechnology giant next year.

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Healthcare Shares

Which insider sold $770,000 worth of ResMed shares this week?

What's the situation?

Read more »

Senior woman using cpap machine to stop choking and snoring from obstructive sleep apnoea with bokeh and morning light background.
Healthcare Shares

Here's the outlook on ResMed shares in 2025

Can investors breath easy?

Read more »

businesswoman holds hand out to shake
Mergers & Acquisitions

Is this ASX All Ords stock primed for a takeover offer in 2025?

The ASX All Ords stock could draw the interest of global companies saddled with fading patents.

Read more »

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Healthcare Shares

2 ASX healthcare shares that are screaming buys in December

These might go on the Christmas list.

Read more »

Two lab workers fist pump each other.
Healthcare Shares

2 ASX healthcare small-cap shares to buy now: brokers

These 2 small-cap healthcare companies have captured the attention of experts.

Read more »

Three rockets heading to space
Share Gainers

3 ASX biotech shares rocketing 10% to 26% on BIG news!

Investors are sending these three ASX biotech stocks flying higher on Thursday.

Read more »

A woman in her late 30s holds her hands out either side with the palms up as if indicating she doesn't know the answer to a question. She has a quizzical look on her face.
Healthcare Shares

What on Earth is happening with Mesoblast shares today?

First it was jumping and then it was sinking. What's going on?

Read more »